2022 Critical Care Pharmacy Preparatory Review and Recertification Course -- Practice Administration and Development: Pharmacoeconomics and Safe Medication Use, Cardiovascular Critical Care I, Research Design, Biostatistics, and Literature Evaluation, Shock Syndromes I: Introduction, Vasodilatory, and Sepsis, Shock Syndromes II: Hypovolemic, Critical Bleeding, and Obstructive

Sunday, April 24, 2022 from 12:30 PM to 5:30 PM CDT
at Academic and Research Building: Second Floor, Room 223
Available for 5.00 hours of CPE credit
Activity Number: 0217-0000-22-092-L04-P

The Critical Care Pharmacy Preparatory Review and Recertification Course is ideal for pharmacy professionals who are preparing for the Board of Pharmacy Specialties (BPS) Critical Care Pharmacy Specialty Certification Examination, for Board Certified Critical Care Pharmacists (BCCCPs) seeking recertification through continuing education, and for those seeking a self-paced review and refresher of critical care pharmacy topics.

Developed and presented by nationally recognized pharmacy faculty, the course content provides a comprehensive review of the knowledge domains covered in the critical care pharmacy specialty. Using a case-based approach, the course strongly emphasizes the thought processes needed to solve patient care problems in each therapeutic area.

Learning Objectives

1. Apply the principles of pharmacoeconomics to patient care.
2. Compare and contrast between a medication error, an adverse drug event (ADE), a preventable ADE, and an adverse drug reaction (ADR).
3. Design an ADE reporting program, including committee structure, committee reporting mechanisms, and methods of detecting, reporting, and managing ADEs.
4. Provide recommendations for improving medication use safety using the 2017 SCCM Safe Medication Use Guidelines for the intensive care unit.
5. Provide safety measures for drug interaction detection and prevention.
6. Develop and implement a drug formulary proposal.
7. Evaluate a patient's hemodynamic status to develop an appropriate pharmacotherapeutic regimen.
8. Design a treatment plan for patients with cardiogenic shock.
9. Develop treatment plans for critically ill patients with cardiovascular diseases, including, but not limited to, coronary artery disease, arrhythmias, heart failure (HF), and disease.
10. Recognize the utility and application of mechanical circulatory support and heart transplantation for patients with advanced HF and cardiogenic shock.
11. Identify factors influencing the conduct of essential critical care research.
12. Evaluate the appropriateness of various statistical tests for a set of data.
13. Apply concepts of research design and analysis to clinical care.
14. Distinguish between the various shock syndromes on the basis of a patient􀂶s clinical and hemodynamic parameters.
15. Interpret hemodynamic data from monitoring devices and markers of perfusion.
16. Devise a treatment strategy for when to use intravenous fluids and/or vasopressors in a patient with shock.
17. Develop a treatment pathway for the care of patients with sepsis or septic shock that incorporates current evidence and the Surviving Sepsis Campaign guideline recommendations.
18. Identify critical determinants affecting oxygen delivery and the physiologic response to hypovolemic and obstructive shock.
19. Evaluate resuscitation strategies and end points in the management of hypovolemic, hemorrhagic, and obstructive shock.
20. Devise a treatment strategy for pharmacotherapy adjuncts in the management of bleeding and acute coagulopathy when treating patients with hemorrhagic shock.
21. Develop a treatment pathway for the care of patients receiving anticoagulants and antiplatelet agents for a life-threatening hemorrhage or critical bleeding that incorporates current evidence and guideline recommendations.
22. Apply risk stratification to guide the effective and safe use of thrombolytic agents in the management of acute pulmonary embolism.

Practice Administration and Development: Pharmacoeconomics and Safe Medication Use 12:30 PM to 1:15 PM Speakers Speaker: Adrian Wong, Pharm.D., MPH, FCCP, FCCM, BCCCP View Biography Wong

Cardiovascular Critical Care I 1:15 PM to 2:15 PM Speakers Speaker: Stephanie Dwyer Kaluzna, Pharm.D. Clinical Assistant Professor / PGY2 Cardiology Residency Program Director University of Illinois Chicago College of Pharmacy Cardiovascular Clinical Pharmacist University of Illinois Hospital and Health Sciences System Chicago, Illinois View Biography Dwyer Kaluzna

Research Design, Biostatistics, and Literature Evaluation 2:25 PM to 3:10 PM Speakers Speaker: Edward T. Van Matre, Pharm.D. Assistant Professor University of Tennessee Health Science Center College of Pharmacy Memphis, Tennessee View Biography Van Matre

Shock Syndromes I: Introduction, Vasodilatory, and Sepsis 3:10 PM to 4:25 PM Speakers Speaker: Gretchen Sacha, Pharm.D. Critical Care Clinical Pharmacy Specialist Cleveland Clinic Cleveland, Ohio View Biography Sacha

Shock Syndromes II: Hypovolemic, Critical Bleeding, and Obstructive 4:25 PM to 5:30 PM Speakers Speaker: Mitchell J. Daley, Pharm.D., BCCCP Market Clinical Pharmacy Specialist, Critical Care, Dell Seton Medical Center at The University of Texas Clinical Assistant Professor, Department of Surgery, Dell Medical School at The University of Texas Austin, Texas View Biography Daley Speaker: Mahmoud Ammar, Pharm.D., BCCCP, BCPS Critical Care Clinical Pharmacy Specialist - Trauma-Surgical, Yale New Haven Health Clinical Associate Professor, University of Connecticut School of Pharmacy New Haven, Connecticut View Biography Ammar